The NICE guidelines for diabetes in pregnancy: Questions and practicalities?

Practical Diabetes International

Volumn 25, Issue 5, 2008, Pages 174-

  Cummings, Michael H ^a  

^a QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN DERIVATIVE; METFORMIN;

CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; EVIDENCE BASED PRACTICE; GLUCOSE TOLERANCE TEST; GLYCEMIC CONTROL; HEMOGLOBIN DETERMINATION; HUMAN; NEWBORN DISEASE; NOTE; OBSTETRIC CARE; PRACTICE GUIDELINE; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; RISK FACTOR;

EID: 54949148743     PISSN: 13578170     EISSN: 1528252X     Source Type: Journal    
DOI: 10.1002/pdi.1240     Document Type: Note

References (3)

1. National Collaborating Centre for Women's and Children's Health. Diabetes in pregnancy: management of diabetes and its complications from preconception to the post natal period. London: National Institute for Health and Clinical Excellence, 2008. http://www.nice.org.uk/CG063
2. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcomes. N Engl J Med 2008; 358: 1991-2002.
3. Rowan JA, Hague WM, Gao W, et al. Metformin versus Insulin for the Treatment of Gestational Diabetes. N Engl J Med 2008; 358: 2003-2015.